Bladder Cancer
Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
January 29, 2025
Predictive value of Bladder EpiCheck® in detecting residual tumor before second TUR for non-muscle-invasive bladder cancer.
January 29, 2025
Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions.
January 28, 2025
Fluid intake and recurrence and progression risk of patients with non-muscle-invasive bladder cancer.
January 28, 2025
Association of Prehabilitation in the Precystectomy Pathway in Patients With Bladder Cancer on Postoperative Outcomes.
January 27, 2025
Impact of race-based calculations of eGFR on the management of muscle invasive bladder cancer.
January 23, 2025
AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses.
January 23, 2025
Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN.
January 23, 2025
Is pT0 a Reliable End Point for Biomarker Discovery for Preoperative Chemotherapy Response in Patients with Bladder Cancer?
January 22, 2025
A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy.
January 22, 2025
Intravesical Administration of Durvalumab for High-risk Non-muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group.
January 22, 2025